The Directors are pleased to present the 30th Annual Report together
 with the Audited Statement of Accounts and the Auditors Report of your
 company for the Year ended 31st March, 2012. The Financial highlights
 for the year under review are given below:
 
 FINANCIAL RESULTS
 
                                                          (Rs.in Lacs)
 
 For the year ended                 31st March, 2012   31st March, 2011
 
 Total Income                                4557.37            5309.68
 
 Profit before Depreciation & Tax             117.79             132.46
 
 Less - Depreciated                            37.20              41.06
 
 Profit before T                               80.59              91.40
 
 Less - Provision for T                        10.28              -0.08
 
 Profit after Tax                              70.31              91.48
 
 For the year ended                 31st March, 2012   31st March, 2011
 
 Add: Balance of Profits for                  435.98             344.50
 earlier years 
 
 Balance available for Appropriation          506.29             435.98
 
 PERFORMANCE
 
 The Total Income for the financial year under review is Rs.4557.37 lacs
 against Rs. 5309.68 lacs in previous year registering a decline of
 about 14.17%. The Net Profit generated by the company during the year
 under review was Rs. 70.31 lacs as compared to Rs. 91.48 lacs during
 the previous year registering a downfall of about 23.14%.
 
 DIVIDEND
 
 Due to growing requirement of funds in business activities, your
 Directors do not propose any dividend for the FY 2011-12 (Previous Year
 - Nil).
 
 DIRECTORS
 
 Mr. Haresh Sunder Das Tareja was appointed as an additional Director of
 the Company w.e.f. 30/05/2012. He holds the office up to the date of
 ensuing Annual General Meeting. The Company has received requisite
 notice together with necessary deposit, as provided under section 257
 of the Companies Act 1956, from a shareholder proposing the appointment
 of Mr.Haresh Sunder Das Talreja as a Director of the Company at the
 ensuing Annual General Meeting.
 
 Mr. Baldev Singh has resigned as Director with effect from 30/05/2012
 due to his preoccupation. The Board placed on record the valuable
 contribution made by him in the deliberations of the meetings of the
 Board and committee (s) during his tenure as a director.
 
 Mr. M. D. Kanther, director of the Company, retires by rotation at the
 ensuing Annual General Meeting and is eligible for reappointment. Your
 directors commend their reappointment
 
 LISTING OF SHARES
 
 Equity shares of the Company are listed with Calcutta Stock Exchange
 and Interconnected Stock Exchange of India. Equity shares of the
 company are also traded under permitted category at Bombay Stock
 Exchange.  Listing fees has already been paid in pursuance to clause 38
 of the listing agreement.
 
 MANAGEMENT & DISCUSSION AND ANALYSIS
 
 In compliance with the provision of clause 49 of the listing agreement
 with the Stock Exchanges, detailed review of the operations,
 performance and future outlook of the Company is annexed hereto.
 
 AUDITORS & AUDITORS OBSERVATION
 
 M/s. Mohindra Arora & Co., Chartered Accountants, the auditors of the
 company who hold office until the conclusion of the forthcoming Annual
 General Meeting, being eligible, offer themselves for re-appointment,
 if made, would be within the prescribed limits under Section 224 (1B)
 of the Companies Act, 1956.
 
 The observations of the Auditors as referred to in the Auditor''s Report
 are properly explained in the financial statements.
 
 FIXED DEPOSITS
 
 The company has not accepted any public deposit and, as such, no amount
 of principal or interest was outstanding on the date of Balance Sheet.
 
 COMPLIANCE WITH THE ACCOUNTING STANDARDS
 
 The Company prepares its accounts and other financial statements in
 accordance with the relevant accounting principles and also complies
 with the Accounting Standards issued by the Institute of Chartered
 Accountants of India.
 
 INTERNAL CONTROL SYSTEMS & THEIR ADEQAUCY
 
 Your Company remains committed to maintain, high standards of internal
 control designed to provide adequate assurance on the efficiency of
 operations and security of its assets. The adequacy and effectiveness
 of the internal control across various activities, as well as
 compliance with laid down systems and policies are comprehensively and
 frequently monitored by your company''s management at all levels of the
 organization. The audit committee, which meets at least four times a
 year, actively reviews internal control systems as well as financial
 disclosure.
 
 CORPORATE GOVERNANCE
 
 A separate section on Corporate Governance is included in the Annual
 Reports and the Certificate from Company''s auditors confirming the
 compliance with the code of Corporate Governance as enumerated in
 clause 49 of the listing of agreements with the Stock Exchange is
 annexed hereto.
 
 HUMAN RESOURCE DEVELOPMENT
 
 The Company believes that people are its biggest strength in line with
 the vision to create a large and world class agri biotech company.
 Human resources are the key pillar for any organization and especially
 so for Mavens Biotech Limited. With this strong belief the Company
 imparts to its employees, regular training for constant development and
 honing up their skills with the latest advanced techniques in the
 relevant area of functioning.
 
 
 DIRECTORS RESPONSIBILITY STATEMENT
 
 Pursuant to the requirement under section 217(2AA) of the Companies
 Act, 1956 with respect to the Directors responsibility statement, it is
 hereby confirmed that::
 
 (i) in the preparation of the annual accounts for the year ended 31st
 March, 2012, the applicable accounting standards have been followed and
 there are no material departures from the same;
 
 (ii) the directors have selected such accounting policies and applied
 them consistently and made judgments and estimates that are reasonable
 and prudent so as to give a true and fair view of the state of
 
 affairs of the company at the end of the financial year 31st March,
 2012 and of the profits of the company for the year ended on that date;
 
 (iii) the directors have taken proper and sufficient care for the
 maintenance of adequate accounting records in accordance with the
 provisions of the Act for safeguarding the assets of the company and
 for preventing and detecting fraud and other irregularities;
 
 (iv) the annual accounts have been prepared on a going concern basis.
 
 CONSERVATION OF ENERGY, TECHNOLOGY ABSORPTION, FOREIGN EXCHANGE
 EARNINGS AND OUTGO,
 
 The statement of particulars under section 217(1)(e) of the Companies
 Act,1956 regarding conservation of energy , technology absorption and
 Foreign exchange earnings and outgo are given below::
 
 a) Your Company, being involved in Trading and IT activities, has not
 consumed energy of any significant level. Accordingly, no measures were
 taken for energy conservation and no investment is required to be for
 reduction of energy consumption.
 
 b) No comment is made on technology absorption, considering the nature
 of activities undertaken by your company during the year under review.
 
 c) No Expenditure has been made for research and development during the
 year under review. However, as the company, moves into the new areas of
 business development of seed production and manufacture of secondary
 nutrients and neem based products, the company will establish an R & D
 laboratory that will be directed towards creation of new products,
 development of advanced techniques & process and will help in the
 development of the company.
 
 d) There were no Foreign Exchange earnings or out go during the year
 under review.
 
 PARTICULARS OF EMPLOYEES
 
 None of the employees of the Company was in receipt of remuneration
 exceeding the limits prescribed under section 217(2A) of the Companies
 Act,1956 read with companies ( Particulars of employees) Rules 1975.
 
 ACKNOWLEDGEMENT
 
 The Directors wish to place on record their appreciation of the
 contributions made by the employees at all levels, whose continued
 commitment and dedication helped the company achieve better results.
 The Directors also wish to thank customers, bankers, Central and State
 Governments for their continued support.  Finally your directors would
 like to express their sincere & whole-hearted gratitude to all of you
 for your faith in us and your Co-operation & never failing support.
 
                          For and on behalf of the Board of Directors 
 
                                           For Mavens Biotech Limited
 
 Place : Kolkata 
 
 Date : 03/08/2012
 
                                                     Bharat Kumar Sah
 
                                                (Whole Time Director)